格隆汇2月4日｜松下首席财务官：裁员规模可能扩大至12,000人。

松下首席财务官：裁员规模可能扩大至12000人。(新浪财经) 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

Higher supply this decade will bring stress to LNG market, Vitol exec says Reuters

随着日本大选临近，美元兑日元重新升回1美元兑156日元关口上方，抹去了此前大部分跌幅——此前的回落曾将其推至自去年10月以来的最低水平。日元是今年以来在G10货币中表现最差，而一旦选举这一风险事件过去，下行走势很可能会继续。 日元转而走弱，部分是由于日本首相高市早苗对弱势货币是否有利发表了含糊不清的言论。此外，凯文·沃什被提名为下一任美联储主席，也引发了投资者对他究竟会有多鸽派的担忧。 再结合市场普遍预期高市领导的自民党将在选举中取得显著多数席位，这通常意味着将会实施更为积极的财政政策，从而推升通胀并继续对日元构成压力。 期权市场上，单笔名义金额达1亿美元或以上的美元/日元看涨期权交易量，周二超过看跌期权。随着对美元看涨期权需求增加，用来对冲下跌风险的期权价格已降至近两周低点。 在日本央行显然并不急于加快加息步伐的情况下，美元兑日元最可能的走势方向仍是向160附近迈进。 责任编辑：刘明亮

MoMo Productions/DigitalVision via Getty Images Article Thesis I wrote about Global Payments Inc. ( GPN ), one of the leading online and POS payment platforms, at the beginning of March. At $103.25, I saw the stock as undervalued, especially considering a very low P/E non-GAAP. This is a more useful multiple than P/E GAAP because it excludes non-recurring items, but we needed to pay extra attention in this case because GPN has a long history of acquisitions, with very high goodwill and debt levels. The undervaluation was confirmed by a DCF (Discounted Cash Flow) model; however, I didn’t go with a full stock position because I was not very bullish for a relatively low-growth company with a lot of debt. I opted for a bull Put Spread strategy through options, which has a capped upside potential, but on the other side, it works very well with a flat stock too. But the stock is down today, and my Put Spreads are at a loss. Isn’t it a good time to increase my position? Of course, after reassessing Fair Value, especially after a major restructuring, which will be detailed below. And how, still options or shares? Business Highlights and Economic Moat Global Payments is a payments company with a long history of M&A and which has undergone a major restructuring in recent years. In January, GPN completed the acquisition of Worldpay from FIS and GTCR and divested its Issuer Solutions business segment to FIS, transforming Global Payments into a pure-play merchant solutions provider. They provide payments technology integrated into POS (Point Of Sale) systems, integrated into other business management software solutions, or adapted for online or mobile payments: Global Payments Platform (Investor Presentation) GPN was traditionally more oriented towards SMB (Small and Midsize Business), while Worldpay skews a little bit more towards e-comm and enterprise. Like mentioned in my initial article, with many competitors on the market, it's difficult to see an economic moat. If a mercha...

William Barton/iStock Editorial via Getty Images GSK ( GSK ) shares were up 2% premarket on Wednesday after reporting Q4 results that beat on both lines and reaffirming its earnings growth projection for 2026. The drugmaker generated adjusted EPS of £0.26 on revenue of £8.62B that grew 6% at actual exchange rates (AER) and 8% Y/Y at constant exchange rates (CER). For 2025, sales totaled £32.7B (up +4% AER; +7% at CER), while core operating profit rose +11% at CER to £9.78B. “GSK delivered another strong performance in 2025, driven mainly by Specialty Medicines, with double-digit sales growth in Respiratory, Immunology & Inflammation (RI&I), Oncology and HIV. Good R&D progress also continued, with 5 major product approvals achieved and several acquisitions and new partnerships completed to strengthen the pipeline further in oncology and RI&I,” CEO Luke Miels said. The drugmaker reported Specialty Medicines sales of £13.5B (+17%) for the year; £3.8B sales (+18%) from Respiratory, Immunology & Inflammation; £2.0B (+43%) from Oncology, and £7.7B (+11%) from HIV, while Vaccines sales totaled £9.2B (+2%), led by Shingrix at £3.6B (+8%), meningitis vaccines at £1.6B (+12%), and Arexvy at £0.6B (+2%). General Medicines sales fell 1% at CER to £10B for the year. GSK ( GSK ) reaffirmed its 2026 guidance, expecting turnover growth of 3% to 5%, core operating profit growth of 7% to 9%, and core EPS growth of 7% to 9%, while also reiterating its 2031 sales outlook of more than £40B. The guidance is underpinned by full-year 2026 turnover expectations at CER, with Specialty Medicines projected to deliver low double-digit percentage growth, while Vaccines and General Medicines are each expected to see a low single-digit percentage decline to stable turnover. More on GSK GSK plc (GSK) RAPT Therapeutics, Inc. - M&A Call - Slideshow RAPT Therapeutics: A Buy As GSK Acquisition Highlights Long-Acting IgE Candidate GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference T...

格隆汇2月4日｜Jefferies分析师在一份研究报告中写道，英飞凌科技的第二财季业绩预测符合预期。这家德国芯片制造商表示，截至3月份的该财季收入料将约为38亿欧元，与Jefferies的预估一致。英飞凌的部门业绩利润率（一项关键的盈利能力指标）预计将在百分之十几的中高段，也与Jefferies 17.5%的预测一致。英飞凌股价下跌3%，报39.84欧元。

格隆汇2月4日｜Piper Sandler将Adobe的目标价从470美元下调至330美元，评级从“增持”下调至“中性”。(格隆汇)

格隆汇2月4日｜美股SaaS板块盘前走低。Atlassian跌1.5%，Intuit跌0.9%，Adobe跌0.9%，Salesforce跌0.7%，ServiceNow跌0.8%。消息面上，人工智能公司Anthropic为其Cowork产品推出新工具，投资者担忧AI的快速发展可能颠覆软件公司传统的商业模式。

Euroclear CEO Valérie Urbain joins Bloomberg’s Opening Trade to discuss a record year for earnings and the impact of the European Union’s deliberations over €210 billion in frozen Russian assets - most of them held at the Belgium-based clearing bank - and the implications for Euroclear and its clients. (Source: Bloomberg)

Ashton Thomas Private Wealth LLC lifted its position in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 26.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,032 shares of the electric vehicle producer's stock after acquiring an additional 3,724 shares during the quarter. Ashton Thomas Private Wealth LLC's holdings in Tesla were worth $8,019,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also made changes to their positions in the company. Relyea Zuckerberg Hanson LLC raised its holdings in shares of Tesla by 0.4% in the third quarter. Relyea Zuckerberg Hanson LLC now owns 6,558 shares of the electric vehicle producer's stock worth $2,916,000 after acquiring an additional 23 shares during the last quarter. Equita Financial Network Inc. raised its stake in Tesla by 2.8% in the 3rd quarter. Equita Financial Network Inc. now owns 855 shares of the electric vehicle producer's stock valued at $380,000 after purchasing an additional 23 shares during the last quarter. VanderPol Investments L.L.C. lifted its holdings in Tesla by 2.2% in the 3rd quarter. VanderPol Investments L.L.C. now owns 1,070 shares of the electric vehicle producer's stock valued at $464,000 after purchasing an additional 23 shares in the last quarter. Resonant Capital Advisors LLC boosted its stake in shares of Tesla by 0.3% during the 3rd quarter. Resonant Capital Advisors LLC now owns 8,577 shares of the electric vehicle producer's stock worth $3,814,000 after purchasing an additional 23 shares during the last quarter. Finally, Cloud Capital Management LLC grew its holdings in shares of Tesla by 1.1% during the third quarter. Cloud Capital Management LLC now owns 2,076 shares of the electric vehicle producer's stock worth $923,000 after buying an additional 23 shares in the last quarter. 66.20% of the stock is currently owned by hedge funds and other i...

财联社2月4日讯（编辑 梓隆）， 近期，A股市场迎来部分修复，截至今日（2月4日）收盘， 上证指数 重返4100点，此前经历调整的 上证50 、沪深 300等权 重指数今日涨幅居前。ETF市场方面，主要权重宽基ETF近期的份额缩水态势已显著缓和，其中多个产品出现份额回流。 注：市场主要指数今日涨跌情况（截至2月4日收盘） 宽基赎回压力缓解，多个品种份额回升 作为市场重要风向标之一，权重宽基ETF的动向一直是投资者关注焦点。今年1月中下旬至2月初期间，头部宽基ETF集体遭遇大规模赎回，以目前规模居前的5只 沪深300 、上证50系ETF统计，其基金份额在1月13日至2月2日期间平均减少近52.4%，其中， 沪深300 ETF华夏（510330）近期份额下降最为明显，缩水幅度接近六成，规模也跌破千亿。 注：目前基金规模超10亿元的16只沪深300、上证50系ETF近期份额变动情况（截至2月3日数据） 不过，自2月以来，这些权重宽基ETF份额降幅逐步收窄，并于昨日（2月3日）大面积迎来回流。具体数据上看，同样以目前规模居前的5只沪深300、上证50系ETF为统计样本，其份额昨日平均增长近0.33%，其中，沪深300ETF华夏（510330）表现突出，份额增幅达0.64%，而沪深300ETF华泰柏瑞（510300）昨日份额基本持平，仅增长0.08%。 注：基金规模最大的沪深300ETF近期份额变动情况（截至2月3日数据） 除权重宽基ETF外，近期同样遭大幅赎回的中证1000、 中证500 、创业板、科创板相关ETF昨日份额也同样迎来止跌回升。筛选基金规模超10亿元且在1月13日至2月2日期间份额降幅超三成的上述ETF，7只ETF基金昨日均获部分净申购，其中，规模最高的 中证500 ETF（510500）昨日份额增长近3.9%，中证1000系ETF昨日份额也增长明显。 注：基金规模超10亿元且在1月13日至2月2日期间份额降幅超三成的中证1000、中证500、创业板、科创板相关ETF（截至2月3日数据） 扛旗先锋权重盘点，指数估值水平一览 进入2月以来，部分权重股迎来回升，成为带动指数上涨的扛旗先锋。截至今日收盘，以沪深300成分股作为统计样本，累计共有19股月内涨幅在7%以上。其中， 晶盛机电 、 晶科能源 2股表现尤其活跃，涨幅分别达39.7%、32.7%，同时， 中国东...

Keir Starmer will attempt to get ahead of the widening scandal over Peter Mandelson’s conduct with the expected release of files relating to his appointment as Britain’s US ambassador, in what a minister has described as “drawing a line in the sand”. The Conservatives had been preparing to force the publication of the records – including what Mandelson may have told Starmer about his relationship with the convicted child sex offender Jeffrey Epstein before being appointed to Washington – with a motion in the Commons. Rather than face a difficult vote amid anger among his own MPs, the prime minister has ordered the publication of those records – emails, documents and messages – apart from those deemed prejudicial to national security or that could damage diplomatic relations. It is understood the government’s intention is to be transparent while avoiding a situation where all the communications get published. A government amendment to the Conservatives’ motion that would compel the release of the documents is expected to pass. The Guardian understands that officials are working through the material but that it is unlikely to be ready to be published on Wednesday. The documents identified for release will need to be assessed to check whether they will first need to be seen by the police. Scotland Yard has formally launched a criminal investigation into allegations that Mandelson leaked Downing Street emails and market sensitive information to Epstein. Documents from the Epstein files released in the US appeared to show the then business secretary sent confidential details of internal discussions to the disgraced financier in the aftermath of the financial crash. Wes Streeting, the health secretary, said on Wednesday that the prime minister was going for “maximum transparency” and would be “drawing a line in the sand”. It was clear from the US Department of Justice’s latest release that Mandelson had not told “the whole truth”, said Streeting, adding that the prime min...

Intel teams up with SoftBank’s Saimemory for future memory rollout. Credit: Michael Vi/Shutterstock.com. SoftBank’s subsidiary, Saimemory, has formed an alliance with Intel to advance the commercialisation of Z-Angle Memory (ZAM), a next-generation memory technology. This collaboration aims to address the growing demands for enhanced computational performance in AI and high-performance computing sectors by offering improved memory capacity and bandwidth while reducing power consumption. The timeline set by both parties plans for operational commencement in early 2026, prototype development by fiscal year 2027, and full commercialisation by fiscal year 2029. Saimemory, established in December 2024 and based in Tokyo, focuses on the research and development of next-generation memory solutions. This initiative is part of SoftBank’s broader strategy to enhance Japan’s global competitiveness in the semiconductor industry. SoftBank said that Saimemory’s efforts are integral to the group’s key initiatives supporting future social infrastructure advancements. By collaborating with Intel and other international research institutions, SoftBank seeks to significantly contribute to the development of homegrown semiconductor technologies. In this collaboration, Intel will serve as a technology, innovation, and standards collaborator, while Saimemory will provide technology innovation and lead the commercialisation of ZAM. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. By GlobalData Learn more about Strategic Intelligence The ZAM technology leverages foundational work under the Advanced Memory Technology (AMT) research programme. Managed by the US Department of Energy and National Nuclear Security Administration, the AMT initiative involves contributions from Sandia National Laboratory, Lawrence Livermore National Laboratory, and Los Ala...

SoftBank's subsidiary, Saimemory, has formed an alliance with Intel to advance the commercialisation of Z-Angle Memory (ZAM), a next-generation memory technology. This collaboration aims to address the growing demands for enhanced computational performance in AI and high-performance computing sectors by offering improved memory capacity and bandwidth while reducing power consumption. The timeline set by both parties plans for operational commencement in early 2026, prototype development by fiscal year 2027, and full commercialisation by fiscal year 2029. Saimemory, established in December 2024 and based in Tokyo, focuses on the research and development of next-generation memory solutions. This initiative is part of SoftBank's broader strategy to enhance Japan's global competitiveness in the semiconductor industry. SoftBank said that Saimemory's efforts are integral to the group’s key initiatives supporting future social infrastructure advancements. By collaborating with Intel and other international research institutions, SoftBank seeks to significantly contribute to the development of homegrown semiconductor technologies. In this collaboration, Intel will serve as a technology, innovation, and standards collaborator, while Saimemory will provide technology innovation and lead the commercialisation of ZAM. The ZAM technology leverages foundational work under the Advanced Memory Technology (AMT) research programme. Managed by the US Department of Energy and National Nuclear Security Administration, the AMT initiative involves contributions from Sandia National Laboratory, Lawrence Livermore National Laboratory, and Los Alamos National Laboratory. Intel's participation in the AMT programme is said to have contributed critical proof points and performance validation for the stacked dynamic random-access memory (DRAM) concept, which is central to ZAM's architecture. Furthermore, Intel's advancements through its Next Generation DRAM Bonding (NGDB) initiative showcased hi...

沪深股通今日合计成交3229.04亿，其中 贵州茅台 和 中际旭创 分居 沪股通 和深股通个股成交额首位。板块主力资金方面，电力设备板块主力资金净流入居首。ETF成交方面，煤炭ETF（515220）成交额环比增长335%。期指持仓方面，IH、IF、IC、IM合约多空双方均减仓，空头减仓数量较多。 龙虎榜方面，商业航天概念股 海兰信 盘中冲高回落，两家游资（ 国泰海通 证券成都北一环路、国泰海通证券武汉紫阳东路）分别卖出1.39亿、1.12亿。化工人气股 红宝丽 遭多路资金激烈博弈，其中获两家机构买入0.9亿，深股通买入0.69亿，而一家量化资金（开源证券西安太华路）卖出1.15亿，同时两家一线游资（国泰海通证券武汉紫阳东路、国泰海通证券上海海阳西路）合计卖出2.47亿。 一、沪深股通前十大成交 今日沪股通总成交金额为1533.68亿，深股通总成交金额为1695.37亿。 从沪股通前十大成交个股来看，贵州茅台位居首位； 寒武纪 和 紫金矿业 分居二、三位。 从深股通前十大成交个股来看，中际旭创位居首位； 宁德时代 和 新易盛 分居二、三位。 二、板块个股主力大单资金 从板块表现来看，煤炭、光伏、机场航运等板块涨幅居前，AI应用、贵金属、算力硬件等板块跌幅居前。 从主力板块资金监控数据来看，电力设备板块主力资金净流入居首。 板块资金流出方面，电子板块主力资金净流出居首。 从个股主力资金监控数据来看，主力资金净流入前十的个股所属板块较为分散，宁德时代净流入居首。 主力资金流出前十的个股所属板块较为分散，中际旭创净流出居首。 三、ETF成交 从成交额前十的ETF来看，黄金ETF（518880）成交额位居首位，A500ETF基金（512050）成交额位居次席。 从成交额环比增长前十的ETF来看，煤炭ETF（515220）成交额环比增长335%位居首位；医疗器械ETF（159883）成交额环比增长182%位居次席。 四、期指持仓 四大期指主力合约中，IH、IF、IC、IM合约多空双方均减仓，且空头减仓数量较多。 五、龙虎榜 1、机构 今日龙虎榜机构活跃度有所降低，买入方面，化工人气股红宝丽遭多路资金激烈博弈，获两家机构买入0.9亿，同时深股通买入0.69亿。2连板的 中集集团 获两家机构买入1.41亿，同时遭两家机构卖出3209万。 卖出方面，AI应用概念今日集体退潮，人气股 ...

周三，受欧洲地区一系列企业财报影响，欧洲股市开盘小幅震荡走高。 泛欧斯托克 600 指数在开盘后不久，交易价格略高于平盘线。 早盘交易中，英国富时 100 指数上涨近 0.5%，德国 DAX 指数上涨 0.3%，法国 CAC 40 指数上涨 0.7%，意大利富时 MIB 指数上涨 0.7%。 此前，加密货币和贵金属短暂抛售后，欧洲区域市场企稳，随后迎来此番上涨。 桑坦德银行 股价下跌 3.5%。该行宣布，将以 122 亿美元收购美国地区性银行韦伯斯特银行（Webster Bank）。桑坦德银行还提前一天发布第四季度财报，数据显示，该季度净利润达 37.6 亿欧元（约合 44.5 亿美元），高于市场普遍预期的 34.1 亿欧元；这家西班牙银行同时宣布启动一项新的 50 亿欧元股票回购计划。 诺和诺德 股价在早盘交易中暴跌 18%。该公司于周二提前发布业绩，向投资者预警今年营收和利润增长将下滑。此前，该公司因美国市场降价冲击，以及其重磅减重药物韦戈维（Wegovy）和欧唐平（Ozempic）在中国、巴西、加拿大的专利保护期结束，遭受双重打击。 财报再度成为市场焦点， 诺华 、 葛兰素史克 、英飞凌科技、Equinor、 法国农业信贷 银行、瑞典商业银行、嘉士伯和 OMV 均于周三上午发布财报。 瑞银 股价下跌 1.8%。这家瑞士最大银行公布第四季度净利润 12 亿美元，同比增长 56%，超出分析师预期的 9.19 亿美元，并计划开展 30 亿美元股票回购。 亚太市场隔夜多数下跌，追随华尔街跌势。此前一交易日美国科技股抛售拖累市场情绪，而金价则连续第二个交易日延续涨势。 标普 500 指数相关美股期货隔夜交易价格基本持平。 责任编辑：郭明煜

巴克萊銀行首次給予百濟神州(ONC.US)買入評級，目標價394美元 富途牛牛

恆瑞醫藥(01276)2月4日斥資931.7萬元回購16.5萬股A股 作者 智通財經 Investing.com 香港 - 股市報價& 財經新聞

恆瑞醫藥(01276)2月4日斥資931.7萬元回購16.5萬股A股 作者 智通財經 Investing.com 香港 - 股市報價& 財經新聞

文章提及标的 经纬辉开 -- 经纬辉开（300120）公告，股东兼董事长陈建波于2026/2/3解除质押2765.61万股，占其持股47.70%、占公司总股本4.81%，质权人为永州农村商业银行股份有限公司。截至公告披露日，陈建波持股5797.74万股，持股比例10.09%，累计被质押股份0股；西藏青崖企业管理合伙企业(有限合伙)持股2678.17万股，已全部质押，占公司总股本4.66%；两者合计持股8475.91万股，占14.76%，累计被质押2678.17万股，占31.60%。

格隆汇2月4日｜美国软件公司股价在盘前交易中下跌。Atlassian 公司股价下跌1.5%，财捷集团（Intuit）股价下跌0.9%，Adobe 公司股价下跌0.9%，Salesforce 公司股价下跌0.7%，ServiceNow 公司股价下跌0.8%。云雀恭弥（CrowdStrike）股价下跌1.2%，达塔狗（Datadog）股价下跌0.7%。

格隆汇2月4日｜青达环保公告，股东冰轮环境持有936.09万股，占7.54%；拟因经营需要自2026年3月9日至2026年6月8日通过集中竞价和大宗交易合计减持不超过372.68万股，比例不超3%，其中集中竞价不超124.23万股（1%），大宗交易不超248.45万股（2%）。此前冰轮环境曾于2023年6月8日至2023年6月9日减持23万股，占0.2429%。

周一，埃隆・马斯克强行推动旗下太空公司 SpaceX 与人工智能初创企业 xAI 合并，将其商业帝国中最耀眼的明珠与最亏损的公司合二为一。据知情人士透露，这笔交易对 xAI 估值 2500 亿美元，对 SpaceX 估值 1 万亿美元。此举正值 xAI 奋力追赶 OpenAI、 谷歌 、Anthropic 等竞争对手之际。 这笔交易彰显了这位全球首富在耗资巨大的 AI 竞赛中，正以极快速度争取融资优势。据参与电话会议及知情人士透露，周一下午，SpaceX 首席财务官布雷特・约翰逊在与约 100 名投资者的电话会议上保证，此次合并不会推迟公司计划于今年夏秋两季进行的首次公开募股（IPO）。 约翰逊向投资者表示，SpaceX 已与基石投资者展开洽谈，后者将参与公司 IPO 拟募集的 500 亿美元大额投资。马斯克作为两家公司的控股股东，推动与 xAI 的合并进程迅速推进。 核心要点 合并后 xAI 估值 2500 亿美元，SpaceX 估值 1 万亿美元。 SpaceX 首席财务官向投资者确认，合并预计不会推迟公司计划中的 500 亿美元 IPO。 马斯克计划将 AI 数据中心迁至太空，以降低计算成本。 尽管这一安排将为 xAI 提供更充足的资金缓冲，但也让本应简单直接的 SpaceX 独立 IPO 变得复杂。部分接受《信息》采访的 SpaceX 投资者对此反应消极。 收购私人公司二级市场股权的 Scenic Management 联合创始人兼总裁迈克尔・索贝尔表示，他已接到 SpaceX 股东的电话，这些股东认为，与 xAI 合并后，公司需要向投资者做出更多解释。 “投资者对此十分关注，” 索贝尔说，“如果是纯粹的 SpaceX 独立 IPO，所有人都会极度兴奋。但如果是多家公司的合并，他们虽充满好奇、热切期待，且大多信任马斯克，但心里还是会打个问号。” 自上周四传出 SpaceX 与 xAI 洽谈合并的消息以来，持有 SpaceX 大量股份的电信公司 EchoStar 股价已下跌近 5%，这一表现可视为投资者对这笔交易态度的直接反映。 此次合并凸显了 AI 开发的巨额资金消耗正迫使该领域企业寻找财力雄厚的合作伙伴 —— 要么通过融资，要么如本次案例般与其他业务合并。同时也证明了谷歌等拥有深厚底蕴的大型科技企业的优势：谷歌凭借 Gemini 技术领跑 AI 模型，其现...